Af­ter abor­tion rul­ing, biotechs be­hind nov­el con­tra­cep­tives say tide is turn­ing on in­sur­ance cov­er­age

Credit: Shutterstock

For Whit­ney, the de­sire to even­tu­al­ly have kids sparked a search for a new type of birth con­trol. An­oth­er IUD would pre­vent preg­nan­cy for too long and she need­ed an al­ter­na­tive un­til she was ready for chil­dren. In 2020, she fi­nal­ly found an op­tion she liked: a new vagi­nal ring called An­novera de­vel­oped by Ther­a­peu­tic­sMD. But there was an is­sue. Af­ter chang­ing jobs, her in­sur­ance plan de­nied cov­er­age.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.